Majalah Biomorfologi

Aims & Scope

Majalah Biomorfologi (Biomorphology Journal - MBIOMJ) aims to publish scientific papers with an open-access policy that focus on the variation and modulation of basic and functional biomorphology in humans. The scope of this journal includes anatomy, histology, and bioanthropology. The manuscript contains analysis at the levels of biomolecular, cellular, tissue, organ, and body systems. We also welcome studies based on animal models related to disease and/or abnormalities that occur in humans. The submitted manuscript will be subjected to adouble anonymous peer-reviewto assess the originality of the topic and its contribution to the body of science, the soundness of theory and methodology, analysis coherence, and communicability to the readers. The double-anonymous peer-review means that the identities of both reviewer(s) and author(s) are concealed from each other throughout the review process. The review process is conducted byat least two independent peer reviewers. When two independent peer-reviewers have opposing decisions, the editor-in-chief will make the final decision. The whole process takes approximately5–15 weeks. Majalah Biomorfologi (Biomorphology Journal-MBIOMJ) is published twice a year (January and July). This journal provides immediate open access to its content based on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal (p-ISSN:0215-8833;e-ISSN:2716-0920) is licensed under aCreative Commons Attribution 4.0 International License.

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.